RxDoctor Payments Data

Paul Akerman, MD

Gastroenterology · Providence, RINPI 1942302773

Payments from drug & device makers

What this record shows

This record is dominated by other: $92,046 of the $122,848 with a category attached, or 74.9%. Zimmer Biomet accounts for 74.9% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2024 at $103,208 and has fallen 95.8% since, to $4,347 in 2025. Among gastroenterology clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$122,848in general payments, 2019–2025

Across 366 payments — averaging $335.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$92K
  • Spirus Medical LLC$8K
  • Olympus Corporation Of The Americas$8K
  • Gyrus ACMI, Inc.$5K
  • AbbVie$3K
  • Olympus Corporation$2K
  • plus $5K from 22 others

What the payments were for

  • Consulting fees$22,63118%
  • Speaking & faculty fees$5150%
  • Travel & lodging$1330%
  • Food & beverage$7,5246%
  • Other$92,04675%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$122,848 in reported general payments places this provider in the 95th percentile of 85 gastroenterology providers in Rhode Island.

See all gastroenterology providers in Rhode Island

Medicare billing

Part B allowed, 2024
$104,186
Medicare patients
377
Services billed
817

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexlansoprazole DrDexlansoprazole13$6,346
CholestyramineCholestyramine (With Sugar)21$1,694
Omeprazole98$1,527
Ondansetron OdtOndansetron21$1,202
Cholestyramine LightCholestyramine13$911
Famotidine36$669
Esomeprazole Magnesium17$448
Pantoprazole Sodium35$258

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →